Dec 22
|
14 Cheap DRIP Stocks To Buy Now
|
Dec 21
|
What to Know About the New Fast-Spreading Covid-19 Strain
|
Dec 21
|
M&A market: What will it look like in 2024?
|
Dec 21
|
The Top Healthcare Stocks to Buy With $100
|
Dec 21
|
Weighing Their Chances: 5 Leading Healthcare Companies Fight for Market Share in the $100 Billion Weight-Loss Industry
|
Dec 21
|
Better Bull Market Buy: CRISPR Therapeutics vs. Pfizer Stock
|
Dec 20
|
15 Best Drinks for Sore Throat and Cough
|
Dec 20
|
12 Best Stocks To Buy on Robinhood for Beginners
|
Dec 20
|
12 Most Promising Gene Editing Stocks According to Hedge Funds
|
Dec 20
|
FDA Accepts Merck's (MRK) BLA for 21-Valent Pneumococcal Jab
|
Dec 20
|
Better Dividend Stock: Pfizer or British American Tobacco?
|
Dec 20
|
Pfizer (PFE) Dropped on a Fall-Off in Covid-19 Vaccinations
|
Dec 20
|
Want $1,500 in Dividend Income in 2024? Invest $25,000 in These 3 Top Income Stocks
|
Dec 20
|
3 Stocks Near Multiyear Lows That Could Bounce Back in 2024
|
Dec 19
|
Why Is COVID-19 Vaccine Player CureVac Stock Plummeting Today?
|
Dec 19
|
Why Pfizer Stock Is Bouncing Back
|
Dec 10
|
12 Healthcare Stocks Billionaires Like the Most
|
Dec 10
|
Pfizer marks progress for successor sickle cell drug at ASH
|
Dec 10
|
Marstacimab Phase 3 Data Presented at ASH 2023 Demonstrate Significant Bleed Reduction in Hemophilia A and B
|
Dec 9
|
ASH23: CAR-T for autoimmune disease, real-world questions and sickle cell’s social media mentions
|